Summaries by Inventor Hubler, Zita

Disease-Modifying ASO Therapy for Mitchell Syndrome and Obesity
Bucelli, Robert ; Hubler, Zita ; Miller, Timothy ; Schoch, Kathleen
T-021317

— Published date: 6/2/2026 Value Proposition: First-in-class antisense oligonucleotide (ASO) therapy selectively lowering ACOX1 to enable disease-modifying treatment of Mitchell Syndrome and unlocking a metabolic shift facilitating weight loss. Technology Description: Mitchell Syndrome is an u…